GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (OTCPK:IBOGF) » Definitions » Current Deferred Revenue

IBOGF (Universal Ibogaine) Current Deferred Revenue : $0.08 Mil (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Universal Ibogaine Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Universal Ibogaine's current deferred revenue for the quarter that ended in Jan. 2025 was $0.08 Mil.

Universal Ibogaine Current Deferred Revenue Historical Data

The historical data trend for Universal Ibogaine's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Current Deferred Revenue Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Current Deferred Revenue
Get a 7-Day Free Trial - - 0.13 0.08 0.10

Universal Ibogaine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.22 0.10 0.02 0.08

Universal Ibogaine Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (OTCPK:IBOGF) » Definitions » Current Deferred Revenue
Comparable Companies
TSX:APS TSXV:QPT TSXV:IOT XCNQ:LOBE XCNQ:BLAB TSXV:XRTX XCNQ:GLOW XCNQ:ASEP TSXV:CYTO TSXV:RKV VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
JC4:Germany IBO:Canada
Address
C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Website
https://www.universalibogaine.com
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.